TC
MRK icon

Trilogy Capital’s Merck MRK Stock Holding History

Trilogy Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.14M Sell
40,029
-1,052
-3% -$123K 0.2% 87
2026
Q1 		$4.94M Sell
41,081
-3,154
-7% -$364K 0.22% 73
2025
Q4 		$4.66M Buy
44,235
+977
+2% +$91.7K 0.21% 74
2025
Q3 		$3.63M Sell
43,258
-1,273
-3% -$105K 0.17% 91
2025
Q2 		$3.53M Buy
44,531
+33,904
+319% +$2.69M 0.17% 83
2025
Q1 		$954K Buy
10,627
+458
+5% +$42.8K 0.05% 179
2024
Q4 		$1.01M Sell
10,169
-1,868
-16% -$193K 0.05% 175
2024
Q3 		$1.37M Sell
12,037
-225
-2% -$26.7K 0.07% 165
2024
Q2 		$1.52M Buy
12,262
+6,360
+108% +$819K 0.08% 145
2024
Q1 		$779K Buy
5,902
+3,112
+112% +$384K 0.04% 164
2023
Q4 		$304K Buy
2,790
+437
+19% +$45.4K 0.02% 209
2023
Q3 		$242K Sell
2,353
-986
-30% -$106K 0.02% 235
2023
Q2 		$369K Buy
3,339
+578
+21% +$65.6K 0.02% 198
2023
Q1 		$294K Sell
2,761
-3,221
-54% -$348K 0.02% 219
2022
Q4 		$664K Buy
5,982
+2,334
+64% +$239K 0.05% 146
2022
Q3 		$314K Buy
3,648
+155
+4% +$13.8K 0.03% 147
2022
Q2 		$318K Buy
3,493
+285
+9% +$25.3K 0.03% 133
2022
Q1 		$263K Buy
+3,208
New +$253K 0.02% 152
2019
Q1 		– Sell
-10,383
Closed -$757K – 150
2018
Q4 		$757K Sell
10,383
-832
-7% -$58.7K 0.1% 71
2018
Q3 		$759K Sell
11,215
-1,353
-11% -$86.2K 0.09% 75
2018
Q2 		$728K Sell
12,568
-234
-2% -$13.2K 0.1% 60
2018
Q1 		$665K Buy
+12,802
New +$691K 0.1% 66

Other funds holding MRK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Trilogy Capital's MRK Position: Q2 2026 in Review

Trilogy Capital reduced its Merck (MRK) stake by 2.6% in Q2 2026, selling an estimated $123K and leaving 40,029 shares worth $5.14M. The position accounts for 0.2% of the portfolio, ranked #87.

Trilogy Capital first reported a position in MRK in Q1 2018 and has held it in 22 quarters since. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Trilogy Capital held 40,029 shares of Merck worth $5.14M as of Q2 2026.
  • Trilogy Capital sold 1,052 Merck shares in Q2 2026, an estimated $123K.
  • Merck made up 0.2% of Trilogy Capital's portfolio in Q2 2026, its #87 holding.
  • Trilogy Capital first reported a position in Merck in Q1 2018 and has held it in 22 quarters since.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.